aluates Reports

$ 0.0

Automative

Global Hereditary Angioedema Drug Market Research Report 2025

Published Date: August 2025

Report Code: QYRE-Auto-31C1936

Global Hereditary Angioedema Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Hereditary Angioedema Drug Market Research Report 2025

Code: QYRE-Auto-31C1936

Report

August 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Pharming Group NV

Takeda

CSL Limited

IBio Inc.

BioCryst Pharmaceuticals Inc

Ionis Pharmaceuticals Inc

Hereditary Angioedema Drug Market Size

The global market for Hereditary Angioedema Drug was valued at US$ 819 million in the year 2024 and is projected to reach a revised size of US$ 1290 million by 2031, growing at a CAGR of 6.8% during the forecast period.

Hereditary Angioedema Drug Market

In the past 2 years, the FDA has approved 3 new drugs for prevention or treatment of hereditary angioedema (HAE) in non-pregnant adolescents and adults: the C1 esterase inhibitor Cinryze for prophylaxis and the C1 esterase inhibitor Berinert and the kallikrein inhibitor ecallantide (Kalbitor) for treatment of acute attacks.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hereditary Angioedema Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hereditary Angioedema Drug.

The Hereditary Angioedema Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hereditary Angioedema Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hereditary Angioedema Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hereditary Angioedema Drug Market Report

Report Metric	Details
Report Name	Hereditary Angioedema Drug Market
Accounted market size in year	US$ 819 million
Forecasted market size in 2031	US$ 1290 million
CAGR	6.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	C1 Esterase Inhibitor Kallikrein Inhibitor Selective Bradykinin B2 Receptor Antagonist
Segment by Application	Retail Pharmacies Hospital Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pharming Group NV, Takeda, CSL Limited, IBio Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hereditary Angioedema Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hereditary Angioedema Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Hereditary Angioedema Drug Market growing?

Ans: The Hereditary Angioedema Drug Market witnessing a CAGR of 6.8% during the forecast period 2025-2031.

What is the Hereditary Angioedema Drug Market size in 2031?

Ans: The Hereditary Angioedema Drug Market size in 2031 will be US$ 1290 million.

Who are the main players in the Hereditary Angioedema Drug Market report?

Ans: The main players in the Hereditary Angioedema Drug Market are Pharming Group NV, Takeda, CSL Limited, IBio Inc., BioCryst Pharmaceuticals, Inc., Ionis Pharmaceuticals, Inc.

What are the Application segmentation covered in the Hereditary Angioedema Drug Market report?

Ans: The Applications covered in the Hereditary Angioedema Drug Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Hereditary Angioedema Drug Market report?

Ans: The Types covered in the Hereditary Angioedema Drug Market report are C1 Esterase Inhibitor, Kallikrein Inhibitor, Selective Bradykinin B2 Receptor Antagonist

Recommended Reports

Allergy & Immune Disorders

Genetic & Rare Diseases

Chronic & Cardiovascular

1 Hereditary Angioedema Drug Market Overview

1.1 Product Definition

1.2 Hereditary Angioedema Drug by Type

1.2.1 Global Hereditary Angioedema Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 C1 Esterase Inhibitor

1.2.3 Kallikrein Inhibitor

1.2.4 Selective Bradykinin B2 Receptor Antagonist

1.3 Hereditary Angioedema Drug by Application

1.3.1 Global Hereditary Angioedema Drug Market Value by Application (2024 VS 2031)

1.3.2 Retail Pharmacies

1.3.3 Hospital Pharmacies

1.3.4 Online Pharmacies

1.4 Global Hereditary Angioedema Drug Market Size Estimates and Forecasts

1.4.1 Global Hereditary Angioedema Drug Revenue 2020-2031

1.4.2 Global Hereditary Angioedema Drug Sales 2020-2031

1.4.3 Global Hereditary Angioedema Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Hereditary Angioedema Drug Market Competition by Manufacturers

2.1 Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Hereditary Angioedema Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Hereditary Angioedema Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Hereditary Angioedema Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application

2.7 Global Key Manufacturers of Hereditary Angioedema Drug, Date of Enter into This Industry

2.8 Global Hereditary Angioedema Drug Market Competitive Situation and Trends

2.8.1 Global Hereditary Angioedema Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Hereditary Angioedema Drug Players Market Share by Revenue

2.8.3 Global Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Hereditary Angioedema Drug Market Scenario by Region

3.1 Global Hereditary Angioedema Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Hereditary Angioedema Drug Sales by Region: 2020-2031

3.2.1 Global Hereditary Angioedema Drug Sales by Region: 2020-2025

3.2.2 Global Hereditary Angioedema Drug Sales by Region: 2026-2031

3.3 Global Hereditary Angioedema Drug Revenue by Region: 2020-2031

3.3.1 Global Hereditary Angioedema Drug Revenue by Region: 2020-2025

3.3.2 Global Hereditary Angioedema Drug Revenue by Region: 2026-2031

3.4 North America Hereditary Angioedema Drug Market Facts & Figures by Country

3.4.1 North America Hereditary Angioedema Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Hereditary Angioedema Drug Sales by Country (2020-2031)

3.4.3 North America Hereditary Angioedema Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Hereditary Angioedema Drug Market Facts & Figures by Country

3.5.1 Europe Hereditary Angioedema Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Hereditary Angioedema Drug Sales by Country (2020-2031)

3.5.3 Europe Hereditary Angioedema Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Hereditary Angioedema Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Hereditary Angioedema Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Hereditary Angioedema Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Hereditary Angioedema Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Hereditary Angioedema Drug Market Facts & Figures by Country

3.7.1 Latin America Hereditary Angioedema Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Hereditary Angioedema Drug Sales by Country (2020-2031)

3.7.3 Latin America Hereditary Angioedema Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Hereditary Angioedema Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Hereditary Angioedema Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Hereditary Angioedema Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Hereditary Angioedema Drug Sales by Type (2020-2031)

4.1.1 Global Hereditary Angioedema Drug Sales by Type (2020-2025)

4.1.2 Global Hereditary Angioedema Drug Sales by Type (2026-2031)

4.1.3 Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2031)

4.2 Global Hereditary Angioedema Drug Revenue by Type (2020-2031)

4.2.1 Global Hereditary Angioedema Drug Revenue by Type (2020-2025)

4.2.2 Global Hereditary Angioedema Drug Revenue by Type (2026-2031)

4.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Type (2020-2031)

4.3 Global Hereditary Angioedema Drug Price by Type (2020-2031)

5 Segment by Application

5.1 Global Hereditary Angioedema Drug Sales by Application (2020-2031)

5.1.1 Global Hereditary Angioedema Drug Sales by Application (2020-2025)

5.1.2 Global Hereditary Angioedema Drug Sales by Application (2026-2031)

5.1.3 Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2031)

5.2 Global Hereditary Angioedema Drug Revenue by Application (2020-2031)

5.2.1 Global Hereditary Angioedema Drug Revenue by Application (2020-2025)

5.2.2 Global Hereditary Angioedema Drug Revenue by Application (2026-2031)

5.2.3 Global Hereditary Angioedema Drug Revenue Market Share by Application (2020-2031)

5.3 Global Hereditary Angioedema Drug Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pharming Group NV

6.1.1 Pharming Group NV Company Information

6.1.2 Pharming Group NV Description and Business Overview

6.1.3 Pharming Group NV Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pharming Group NV Hereditary Angioedema Drug Product Portfolio

6.1.5 Pharming Group NV Recent Developments/Updates

6.2 Takeda

6.2.1 Takeda Company Information

6.2.2 Takeda Description and Business Overview

6.2.3 Takeda Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Takeda Hereditary Angioedema Drug Product Portfolio

6.2.5 Takeda Recent Developments/Updates

6.3 CSL Limited

6.3.1 CSL Limited Company Information

6.3.2 CSL Limited Description and Business Overview

6.3.3 CSL Limited Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 CSL Limited Hereditary Angioedema Drug Product Portfolio

6.3.5 CSL Limited Recent Developments/Updates

6.4 IBio Inc.

6.4.1 IBio Inc. Company Information

6.4.2 IBio Inc. Description and Business Overview

6.4.3 IBio Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 IBio Inc. Hereditary Angioedema Drug Product Portfolio

6.4.5 IBio Inc. Recent Developments/Updates

6.5 BioCryst Pharmaceuticals, Inc.

6.5.1 BioCryst Pharmaceuticals, Inc. Company Information

6.5.2 BioCryst Pharmaceuticals, Inc. Description and Business Overview

6.5.3 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio

6.5.5 BioCryst Pharmaceuticals, Inc. Recent Developments/Updates

6.6 Ionis Pharmaceuticals, Inc.

6.6.1 Ionis Pharmaceuticals, Inc. Company Information

6.6.2 Ionis Pharmaceuticals, Inc. Description and Business Overview

6.6.3 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product Portfolio

6.6.5 Ionis Pharmaceuticals, Inc. Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Hereditary Angioedema Drug Industry Chain Analysis

7.2 Hereditary Angioedema Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Hereditary Angioedema Drug Production Mode & Process Analysis

7.4 Hereditary Angioedema Drug Sales and Marketing

7.4.1 Hereditary Angioedema Drug Sales Channels

7.4.2 Hereditary Angioedema Drug Distributors

7.5 Hereditary Angioedema Drug Customer Analysis

8 Hereditary Angioedema Drug Market Dynamics

8.1 Hereditary Angioedema Drug Industry Trends

8.2 Hereditary Angioedema Drug Market Drivers

8.3 Hereditary Angioedema Drug Market Challenges

8.4 Hereditary Angioedema Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Pharming Group NV

Takeda

CSL Limited

IBio Inc.

BioCryst Pharmaceuticals Inc

Ionis Pharmaceuticals Inc

List of Tables

Table 1. Global Hereditary Angioedema Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Hereditary Angioedema Drug Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Hereditary Angioedema Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Hereditary Angioedema Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Hereditary Angioedema Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Hereditary Angioedema Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Hereditary Angioedema Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Hereditary Angioedema Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Hereditary Angioedema Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Hereditary Angioedema Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Hereditary Angioedema Drug, Product Type & Application

Table 12. Global Key Manufacturers of Hereditary Angioedema Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Hereditary Angioedema Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Hereditary Angioedema Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Hereditary Angioedema Drug Sales Market Share by Region (2020-2025)

Table 19. Global Hereditary Angioedema Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Hereditary Angioedema Drug Sales Market Share by Region (2026-2031)

Table 21. Global Hereditary Angioedema Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Hereditary Angioedema Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Hereditary Angioedema Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Hereditary Angioedema Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Hereditary Angioedema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Hereditary Angioedema Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Hereditary Angioedema Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Hereditary Angioedema Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Hereditary Angioedema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Hereditary Angioedema Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Hereditary Angioedema Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Hereditary Angioedema Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Hereditary Angioedema Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Hereditary Angioedema Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Hereditary Angioedema Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Hereditary Angioedema Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Hereditary Angioedema Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Hereditary Angioedema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Hereditary Angioedema Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Hereditary Angioedema Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Hereditary Angioedema Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Hereditary Angioedema Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Hereditary Angioedema Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Hereditary Angioedema Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Hereditary Angioedema Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Hereditary Angioedema Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Hereditary Angioedema Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Hereditary Angioedema Drug Sales Market Share by Type (2020-2025)

Table 53. Global Hereditary Angioedema Drug Sales Market Share by Type (2026-2031)

Table 54. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Hereditary Angioedema Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Hereditary Angioedema Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Hereditary Angioedema Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Hereditary Angioedema Drug Sales (K Units) by Application (2020-2025)

Table 61. Global Hereditary Angioedema Drug Sales (K Units) by Application (2026-2031)

Table 62. Global Hereditary Angioedema Drug Sales Market Share by Application (2020-2025)

Table 63. Global Hereditary Angioedema Drug Sales Market Share by Application (2026-2031)

Table 64. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Hereditary Angioedema Drug Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Hereditary Angioedema Drug Revenue Market Share by Application (2020-2025)

Table 67. Global Hereditary Angioedema Drug Revenue Market Share by Application (2026-2031)

Table 68. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2020-2025)

Table 69. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2026-2031)

Table 70. Pharming Group NV Company Information

Table 71. Pharming Group NV Description and Business Overview

Table 72. Pharming Group NV Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pharming Group NV Hereditary Angioedema Drug Product

Table 74. Pharming Group NV Recent Developments/Updates

Table 75. Takeda Company Information

Table 76. Takeda Description and Business Overview

Table 77. Takeda Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Takeda Hereditary Angioedema Drug Product

Table 79. Takeda Recent Developments/Updates

Table 80. CSL Limited Company Information

Table 81. CSL Limited Description and Business Overview

Table 82. CSL Limited Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. CSL Limited Hereditary Angioedema Drug Product

Table 84. CSL Limited Recent Developments/Updates

Table 85. IBio Inc. Company Information

Table 86. IBio Inc. Description and Business Overview

Table 87. IBio Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. IBio Inc. Hereditary Angioedema Drug Product

Table 89. IBio Inc. Recent Developments/Updates

Table 90. BioCryst Pharmaceuticals, Inc. Company Information

Table 91. BioCryst Pharmaceuticals, Inc. Description and Business Overview

Table 92. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. BioCryst Pharmaceuticals, Inc. Hereditary Angioedema Drug Product

Table 94. BioCryst Pharmaceuticals, Inc. Recent Developments/Updates

Table 95. Ionis Pharmaceuticals, Inc. Company Information

Table 96. Ionis Pharmaceuticals, Inc. Description and Business Overview

Table 97. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Ionis Pharmaceuticals, Inc. Hereditary Angioedema Drug Product

Table 99. Ionis Pharmaceuticals, Inc. Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Hereditary Angioedema Drug Distributors List

Table 103. Hereditary Angioedema Drug Customers List

Table 104. Hereditary Angioedema Drug Market Trends

Table 105. Hereditary Angioedema Drug Market Drivers

Table 106. Hereditary Angioedema Drug Market Challenges

Table 107. Hereditary Angioedema Drug Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Hereditary Angioedema Drug

Figure 2. Global Hereditary Angioedema Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Hereditary Angioedema Drug Market Share by Type: 2024 & 2031

Figure 4. C1 Esterase Inhibitor Product Picture

Figure 5. Kallikrein Inhibitor Product Picture

Figure 6. Selective Bradykinin B2 Receptor Antagonist Product Picture

Figure 7. Global Hereditary Angioedema Drug Market Value by Application (2020-2031) & (US$ Million)

Figure 8. Global Hereditary Angioedema Drug Market Share by Application: 2024 & 2031

Figure 9. Retail Pharmacies

Figure 10. Hospital Pharmacies

Figure 11. Online Pharmacies

Figure 12. Global Hereditary Angioedema Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Hereditary Angioedema Drug Market Size (2020-2031) & (US$ Million)

Figure 14. Global Hereditary Angioedema Drug Sales (2020-2031) & (K Units)

Figure 15. Global Hereditary Angioedema Drug Average Price (USD/Unit) & (2020-2031)

Figure 16. Hereditary Angioedema Drug Report Years Considered

Figure 17. Hereditary Angioedema Drug Sales Share by Manufacturers in 2024

Figure 18. Global Hereditary Angioedema Drug Revenue Share by Manufacturers in 2024

Figure 19. Global 5 and 10 Largest Hereditary Angioedema Drug Players: Market Share by Revenue in Hereditary Angioedema Drug in 2024

Figure 20. Hereditary Angioedema Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 21. Global Hereditary Angioedema Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 22. North America Hereditary Angioedema Drug Sales Market Share by Country (2020-2031)

Figure 23. North America Hereditary Angioedema Drug Revenue Market Share by Country (2020-2031)

Figure 24. U.S. Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Canada Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Europe Hereditary Angioedema Drug Sales Market Share by Country (2020-2031)

Figure 27. Europe Hereditary Angioedema Drug Revenue Market Share by Country (2020-2031)

Figure 28. Germany Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. France Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. U.K. Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Italy Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Russia Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Asia Pacific Hereditary Angioedema Drug Sales Market Share by Region (2020-2031)

Figure 34. Asia Pacific Hereditary Angioedema Drug Revenue Market Share by Region (2020-2031)

Figure 35. China Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Japan Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. South Korea Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. India Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Australia Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. China Taiwan Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Indonesia Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Thailand Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Malaysia Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Latin America Hereditary Angioedema Drug Sales Market Share by Country (2020-2031)

Figure 45. Latin America Hereditary Angioedema Drug Revenue Market Share by Country (2020-2031)

Figure 46. Mexico Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Brazil Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Argentina Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Middle East and Africa Hereditary Angioedema Drug Sales Market Share by Country (2020-2031)

Figure 50. Middle East and Africa Hereditary Angioedema Drug Revenue Market Share by Country (2020-2031)

Figure 51. Turkey Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Saudi Arabia Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. UAE Hereditary Angioedema Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Global Sales Market Share of Hereditary Angioedema Drug by Type (2020-2031)

Figure 55. Global Revenue Market Share of Hereditary Angioedema Drug by Type (2020-2031)

Figure 56. Global Hereditary Angioedema Drug Price (USD/Unit) by Type (2020-2031)

Figure 57. Global Sales Market Share of Hereditary Angioedema Drug by Application (2020-2031)

Figure 58. Global Revenue Market Share of Hereditary Angioedema Drug by Application (2020-2031)

Figure 59. Global Hereditary Angioedema Drug Price (USD/Unit) by Application (2020-2031)

Figure 60. Hereditary Angioedema Drug Value Chain

Figure 61. Channels of Distribution (Direct Vs Distribution)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global HAE Treatments Market Research Report 2024

C1 Esterase Inhibitor Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global C1 INH Replacement Therapy Market Research Report 2024

Global Hereditary Angioedema Therapeutic Market Insights Forecast to 2030

Global Icatibant Acetate API Market Research Report 2024

Global Icatibant Acetate Injection Market Research Report 2024

Global Icatibant Acetate Market Research Report 2024

Global Hereditary Angioedema Treatment Market Insights Forecast to 2030

Global C1 Esterase Inhibitors Market Research Report 2024

Global Kallikrein Inhibitors Market Research Report 2024

Global Icatibatide Acetate Market Research Report 2024

C1 Esterase Inhibitor Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Stanozolol Market Research Report 2024

Global Nonstatin Cholesterol Medications Market Research Report 2024

Global Complement Inhibitors Market Research Report 2024

Global Bradykinin Receptor Antagonists Market Research Report 2024

Global Panobinostat Market Research Report 2024

Anaphylaxis Treatment Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Epinephrine Autoinjector Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions